Daily variation in fine and ultrafine particulate air pollution and urinary concentrations of lung Clara cell protein CC16

Occupational and Environmental Medicine

Volumn 61, Issue 11, 2004, Pages 908-914

  Timonen, K L ^a   Hoek, G ^b   Heinrich, J ^c   Bernard, A ^d   Brunekreef, B ^b   De Hartog, J ^b   Hameri K ^e   Ibald Mulli, A ^c   Mirme, A ^f   Peters, A ^c   Tiittanen, P ^g   Kreyling, W G ^c   Pekkanen, J ^h  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b UTRECHT UNIVERSITY   (Netherlands)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

^d UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^e UNIVERSITY OF HELSINKI   (Finland)

^f UNIVERSITY OF TARTU   (Estonia)

^g NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^h National Public Health Institute ^*

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; CLARA CELL PROTEIN; CORTICOSTEROID; PROTEIN CC16; UNCLASSIFIED DRUG;

ADULT; AGED; AIR POLLUTANT; AIR POLLUTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CLARA CELL; ENVIRONMENTAL EXPOSURE; EUROPE; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG ALVEOLUS CELL; LUNG ALVEOLUS EPITHELIUM; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PARTICULATE MATTER; PRIORITY JOURNAL; PROTEIN SECRETION; RESPIRATORY TRACT DISEASE; URINALYSIS;

AGED; AIR POLLUTANTS; BIOLOGICAL MARKERS; CARBON DIOXIDE; FEMALE; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; NITROGEN DIOXIDE; PARTICLE SIZE; RESPIRATORY MUCOSA; UTEROGLOBIN;

EID: 6344261910     PISSN: 13510711     EISSN: None     Source Type: Journal    
DOI: 10.1136/oem.2004.012849     Document Type: Article

References (29)

1. Brunekreef B, Holgate ST. Air pollution and health. Lancet 2002;360:1233-42.
2. Künzli N, Kaiser R, Medina S, et al. Public-health impact of outdoor and traffic related air pollution: a European assessment. Lancet 2000;356;795-801.
3. Committee of the Environmental and Occupational Health Assembly of the American Thoracic Society. Health effects of outdoor air pollution. Am J Respir Crit Care Med 1996;153:3-50.
4. Hermans C, Bernard A. Lung epithelium-specific proteins. Characteristics and potential applications as markers. State-of-the-art. Am J Respir Crit Care Med 1999;159:646-78.
5. Hermans C, Bernard A. Pneumoproteinaemia: a new perspective in the assessment of lung disorders. Eur Respir J 1998;11:801-3.
6. Arsalane K, Broeckaert F, Knoops B, et al. Clara cell specific protein (CC16) expression after acute lung inflammation induced by intratracheal lipopolysaccharide administration. Am J Respir Crit Care Med 2000;161:1624-30.
7. Broeckaert F, Bernard A. Clara cell secretory protein (CC16): characteristics and perspectives as lung peripheral biomarker. Clin Exp Allergy 2000;30:469-75.
8. Hermans C, Knoops B, Wiedig M, et al. Clara cell protein as a marker of Clara cell damage and bronchoalveolar blood barrier permeability. Eur Respir J 1999;13:1014-21.
9. Robin M, Dong P, Hermans C, et al. Serum levels of CC16, SP-A and SP-B reflect tobacco-smoke exposure in asymptomatic subjects. Eur Respir J 2002;20:1152-61.
10. Bernard A, Hermans C, van Houte G. Transient increase of serum CC16 protein after exposure to smoke. Occup Environ Med 1997;54:63-5.
11. Burgess JL, Nanson CJ, Bolstad-Johnson DM, et al. Adverse respiratory effects following overhaul in firefighters. J Occup Environ Med 2001;43:467-73.
12. Broeckaert F, Arsalene K, Hermans C, et al. Serum clara cell protein: a sensitive biomarker of increased lung epithelium permeability caused by ambient ozone. Environ Health Perspect 2000;108:533-7.
13. Carbonnelle S, Francaux M, Doyle I, et al. Changes in serum pneumoproteins caused by a short-term exposures to nitrogen trichloride in indoor chlorinated swimming pools. Biomarkers 2002;7:464-78.
14. Cassee FR, Boere AJ, Bos J, et al. Effects of diesel exhaust enriched concentrated PM2.5 in ozone preexposed or monocrotaline-treated rats. Inhal Toxicol 2002;14:721-43.
15. Pekkanen J, Timonen KL, Tiittanen P, et al. ULTRA, Exposure and risk assessment for fine and ultrafine particles in ambient air. Study manual and data book. Kuopio, Publications of National Public Health Institute B9/2000, 2000 (available at www.ktl.fi/ultra).
16. Bernard A, Marchandise FX, Depelchin S, et al. Clara cell protein in serum and bronchoalveolar lavage. Eur Respir J 1992;5:1231-8.
17. Tuch T, Mirme A, Tamm E, et al. Comparison of two particle size spectrometers for ambient aerosol measurements in environmental epidemiology. Atmos Environ 2000;34:139-49.
18. Khlystov A, Kos GPA, ten Brink HM, et al. Intercomparison using laboratory-generated aerosols. Atmos Environ 2001;35:2045-51.
19. 2.5 particles in three European cities. Atmos Environ 2001;35:3729-38.
20. Janssen NAH, de Hartog JJ, Hoek G, et al. Personal exposure to fine particulate matter in elderly subjects: relation between personal, indoor and outdoor concentrations. J Air Waste Manag Assoc 2000;50:1133-43.
21. SAS Institute Inc. SAS/STAT software: changes and enhancements through release 6.11. Cary, NC: SAS Institute Inc., 1989:531-656.
22. S-Plus. 2000 guide to statistics, volume 1. Seattle, WA: Data Analysis Products Division, Mathsoft, 1999:326-7.
23. Normand S-LT. Tutorial in biostatistics. Meta-analysis: formulating, evaluating, combining, and reporting, Stat Med 1999;18:321-59.
24. Berkey CS, Laird NM. Nonlinear growth curve analysis: estimating the population parameters. Ann Human Biol 1986;13:111-28.
25. Arsalene K, Broeckaert F, Knoops B, et al. Increased serum and urinary concentrations of lung Clara cell protein in rats acutely exposed to ozone. Toxicol Appl Pharmacol 1999;159:169-74.
26. Timonen KL, Vanninen E, de Hartog J, et al. Effects of ultrafine and fine particles on heart rate variability in subjects with coronary heart disease [abstract]. Am J Respir Crit Care Med 2001;163:A236.
27. Pekkanen J, Peters A, Hoek G, et al. Particulate air pollution and risk of ST-segment depression during repeated submaximal exercise tests among subjects with coronary heart disease. The exposure and risk assessment for fine and ultrafine particles in ambient air (ULTRA) study. Circulation 2002;106:933-8.
28. de Hartog JJ, Hoek G, Peters A, et al. Effects of fine and ultrafine particles on cardiorespiratory symptoms in elderly subjects with coronary heart disease. The ULTRA study. Am J Epidemiol 2003;157:613-23.
29. Vallius M, Janssen NAH, Heinrich G, et al. Sources and elemental composition of ambient PM2.5 in three European cities. Sci Total Environ. In press.